Patented Medicine Prices Review Board
We are in the process of moving our services and information to Canada.ca.
Our current Patented Medicine Prices Review Board website will remain available until the move to Canada.ca is complete.
The Patented Medicine Prices Review Board launched a 30-day public consultation on its updated draft pricing Guidelines.
Biologics in CanadaThe Biologics in Canada series examines Canadian and international trends in the sales, cost, use, and pricing of biologics as of the end of 2018
What we are doing
The PMPRB is responsible for ensuring the prices that patentees charge for prescription and non-prescription patented medicines sold in Canada to wholesalers, hospitals, pharmacies or others, for human and veterinary use, are not excessive.
Effective and meaningful stakeholder involvement is essential to enable the PMPRB to fulfil its mandate, deliver programs, launch new initiatives, and build public trust.
Report a problem or mistake on this page
- Date modified: